You can buy or sell MIST and other stocks, options, ETFs, and crypto commission-free!
Milestone Pharmaceuticals Inc. Common Shares, also called Milestone Pharmaceuticals, is a biopharmaceutical company. Read More It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada. The listed name for MIST is Milestone Pharmaceuticals Inc. Common Shares.
52 Week High
52 Week Low
— per share
Expected Nov 12, Pre-Market